ARPA-H pledges $160M for custom gene-editing drugs

ARPA-H, the US health agency focused on high-risk research, is funding seven labs with $160 million to develop custom gene-editing treatments. This initiative aims to create personalized medicines for rare diseases, moving beyond one-size-fits-all drug development.